Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Immunic | IMUX | 10. jan 2025 | 1.05 | -4.55 |
ImmunityBio | IBRX | 10. jan 2025 | 2.42 | -5.47 |
Immunocore ADR | IMCR | 10. jan 2025 | 30.40 | +0.56 |
Immunome | IMNM | 10. jan 2025 | 10.60 | -0.56 |
ImmunoPrecise Antibodies | IPA | 10. jan 2025 | 0.53 | -2.85 |
Immunovant | IMVT | 10. jan 2025 | 23.48 | -0.63 |
Immutep ADR | IMMP | 10. jan 2025 | 2.01 | +0.50 |
Imperial Oil | IMO | 10. jan 2025 | 66.86 | +0.84 |
Imperial Petroleum | IMPP | 10. jan 2025 | 3.30 | +3.13 |
Imperial Petroleum A Pref | IMPPP | 10. jan 2025 | 25.00 | +0.32 |
Impinj | PI | 10. jan 2025 | 143.62 | -4.45 |
Imunon | IMNN | 10. jan 2025 | 0.90 | -1.06 |
IN8bio | INAB | 10. jan 2025 | 0.32 | +3.42 |
Inari Medical | NARI | 10. jan 2025 | 79.29 | -0.01 |
Incannex Healthcare ADR | IXHL | 10. jan 2025 | 1.85 | +1.09 |
Inception Growth Acquisition | IGTA | 10. jan 2025 | 11.75 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | 10. jan 2025 | 12.00 | 0.00 |
Income Opportunity Realty Investors | IOR | 10. jan 2025 | 18.16 | 0.00 |
Incyte | INCY | 10. jan 2025 | 70.54 | -3.54 |
Indaptus Therapeutics | INDP | 10. jan 2025 | 0.95 | -2.06 |
Independence Realty Trust | IRT | 10. jan 2025 | 18.23 | -3.03 |
Independent Bank | INDB | 10. jan 2025 | 60.31 | -3.27 |
Independent Bank | IBCP | 10. jan 2025 | 32.75 | -2.70 |
Independent Bank Group | IBTX | 10. jan 2025 | 60.67 | 0.00 |
India Bull 3X Direxion | INDL | 10. jan 2025 | 56.23 | -4.27 |
India Consumer Egshares | INCO | 10. jan 2025 | 63.17 | -1.71 |
India Earnings Wisdomtree | EPI | 10. jan 2025 | 43.89 | -2.49 |
India Fund | IFN | 10. jan 2025 | 15.92 | -1.67 |
India Powershares | PIN | 10. jan 2025 | 25.06 | -2.30 |
Indie Semiconductor A | INDI | 10. jan 2025 | 4.16 | -2.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.